Patient-derived Xenograft (PDX) Models, Global Market Size Forecast, Top 10 Players Rank and Market | |
Patient-derived Xenograft (PDX) Models Market Summary According to the new market research report “Global Patient-derived Xenograft (PDX) Models Market Report 2023-2029”, published by QYResearch, the global Patient-derived Xenograft (PDX) Models market size is projected to reach USD 0.61 billion by 2029, at a CAGR of 9.1% during the forecast period. According to QYResearch Top Players Research Center, the global key manufacturers of Patient-derived Xenograft (PDX) Models include CrownBio, champion tumor, WuXi AppTec, Jackson Laboratory, EPO Berlin-Buch, Oncodesign, Xentech, Envigo, charles river laboratory, Pharmatest Services, etc. In 2022, the global top 10 players had a share approximately 13.1% in terms of revenue. | |
Target Nation: All Nations Target City : All Cities Last Update : 20 March 2024 1:50 AM Number of Views: 84 | Item Owner : Frank Contact Email: (None) Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |